Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells.
about
Ethanol extract of Angelica gigas inhibits croton oil-induced inflammation by suppressing the cyclooxygenase - prostaglandin pathway.Decursinol angelate inhibits PGE2-induced survival of the human leukemia HL-60 cell line via regulation of the EP2 receptor and NFκB pathway.Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid β-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPKA synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo.Protective effects of decursin and decursinol angelate against amyloid β-protein-induced oxidative stress in the PC12 cell line: the role of Nrf2 and antioxidant enzymes.Inhibition of cyclooxygenase-2-dependent survivin mediates decursin-induced apoptosis in human KBM-5 myeloid leukemia cellsIn vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin.UV irradiation increases ROS production via PKCdelta signaling in primary murine fibroblasts.Natural Korean Medicine Dang-Gui: Biosynthesis, Effective Extraction and Formulations of Major Active Pyranocoumarins, Their Molecular Action Mechanism in Cancer, and Other Biological Activities.Decursin and decursinol angelate: molecular mechanism and therapeutic potential in inflammatory diseases.Decursinol and decursin protect primary cultured rat cortical cells from glutamate-induced neurotoxicity.Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
P2860
Q33708777-143845E8-5856-48EE-8F36-D52D3C3EE900Q36077235-444E9D2C-86D9-4F19-804A-212282A139ABQ36465269-5BDBDD3F-69B2-4842-94DF-0F4628B8D003Q36879814-90ABF8BD-885A-4643-AFB8-5296D536FE73Q39484147-BC991263-870F-4457-8418-264A93BAC9D1Q39578575-0018CDED-AFB0-4165-A7BE-25AF0CECDBE1Q39673400-408E1F3F-13C5-41DC-9903-79EA9B988DD7Q39883100-FCC3BBED-46C6-4D09-AA6A-01A912B84AD6Q42437003-1403B127-F53A-4607-8275-B0C279E5D60BQ46246069-005ECBEF-8F0B-48E3-A81A-480F0BDC7E54Q47351858-1BF8D9DD-865B-4EA1-8F12-346BB08ADF76Q48102048-14EC54E1-228D-4776-9F86-66867B767ED6Q51812427-580258A4-7E8D-4FA9-B56B-E54DBFEE04E8
P2860
Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Involvement of PKC and ROS in ...... and U937 myeloleukemia cells.
@en
Involvement of PKC and ROS in ...... and U937 myeloleukemia cells.
@nl
type
label
Involvement of PKC and ROS in ...... and U937 myeloleukemia cells.
@en
Involvement of PKC and ROS in ...... and U937 myeloleukemia cells.
@nl
prefLabel
Involvement of PKC and ROS in ...... and U937 myeloleukemia cells.
@en
Involvement of PKC and ROS in ...... and U937 myeloleukemia cells.
@nl
P2093
P1433
P1476
Involvement of PKC and ROS in ...... and U937 myeloleukemia cells.
@en
P2093
Hyeon Ho Kim
Ik-Hwan Kim
Jin Seok Choi
Sung Sik Bang
P304
P356
10.1016/J.CANLET.2004.10.025
P407
P577
2004-12-08T00:00:00Z